Ganesh Pharmaceuticals

Common size/ Vertical Analysis Income statement: we d

31-Mar-16 Common Size Balance: divide all items
Total Revenue ₹ 8,100,000 100%
Cost of Revenue ₹ 5,346,000 66%
Gross Profit ₹ 2,754,000 34%
Total Operating Expenses ₹ 1,707,480 21%
Operating Income or Loss ₹ 1,046,520 13%
Interest Expense ₹ 345,352 4%

Income Before Tax ₹ 701,168 9%

Income Tax Expense ₹ 210,351 3%

Net Income ₹ 490,818 6%
Income statement: we divide all items by total revenue
Balance: divide all items by Total Assets
Ganesh Pharmaceuticals Revenue - Expenses = Profits
Income Statement:

31-Mar-13 31-Mar-14 31-Mar-15 31-Mar-16

Total Revenue ₹ 6,000,000 ₹ 6,720,000 ₹ 7,500,000 ₹ 8,100,000
Cost of Revenue ₹ 3,600,000 ₹ 4,166,400 ₹ 4,875,000 ₹ 5,346,000
Gross Profit ₹ 2,400,000 ₹ 2,553,600 ₹ 2,625,000 ₹ 2,754,000
Total Operating Expenses ₹ 1,440,000 ₹ 1,532,160 ₹ 1,601,250 ₹ 1,707,480
Operating Income or Loss ₹ 960,000 ₹ 1,021,440 ₹ 1,023,750 ₹ 1,046,520
Interest Expense ₹ 240,000 ₹ 306,432 ₹ 276,413 ₹ 345,352
Income Before Tax ₹ 720,000 ₹ 715,008 ₹ 747,338 ₹ 701,168
Income Tax Expense ₹ 216,000 ₹ 214,502 ₹ 224,201 ₹ 210,351
Net Income ₹ 504,000 ₹ 500,506 ₹ 523,136 ₹ 490,818
Horizontal Analysis
2013 2014 2015
Total Revenue 100% 112% 125%
Cost of Revenue 100% 116% 135%
Gross Profit 100% 106% 109%
Total Operating Expenses 100% 106% 111%
Operating Income or Loss 100% 106% 107%
Interest Expense 100% 128% 115%
Income Before Tax 100% 99% 104%
Income Tax Expense 100% 99% 104%
Net Income 100% 99% 104%

Total Revenue
160%
135%
140% 125%
120% 112%
100%
100%
80%
60%
40%
20%
0%
2013 2014 2015 2016
 2016 Note: The data is partly based on actuals and partly on assumptions
135%
149%
115%
119%
109%
144%
97%
97%
97%

135%

2016